The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer.

breast cancer chemotherapy circulating tumor DNA liquid biopsy recurrence

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
29 Jul 2021
Historique:
received: 08 07 2021
revised: 24 07 2021
accepted: 27 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 8 8 2021
Statut: epublish

Résumé

With the incidence of breast cancer steadily rising, it is important to explore novel technologies that can allow for earlier detection of disease as well more a personalized and effective treatment approach. The concept of "liquid biopsies" and the data they provide have been increasingly studied in the recent decades. More specifically, circulating tumor DNA (ctDNA) has emerged as a potential biomarker for various cancers, including breast cancer. While methods such as mammography and tissue biopsies are the current standards for the detection and surveillance of breast cancer, ctDNA analysis has shown some promise. This review discusses the versatility of ctDNA by exploring its multiple emerging uses for the management of breast cancer. Its efficacy is also compared to current biomarkers and technologies.

Identifiants

pubmed: 34359713
pii: cancers13153813
doi: 10.3390/cancers13153813
pmc: PMC8345044
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Cancer Biomark. 2012;11(2-3):89-98
pubmed: 23011155
Sci Transl Med. 2015 Aug 26;7(302):302ra133
pubmed: 26311728
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8817-22
pubmed: 12857956
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Biosci Rep. 2018 Jul 31;38(4):
pubmed: 29914973
Clin Cancer Res. 2014 May 15;20(10):2643-2650
pubmed: 24504125
Breast Cancer. 2003;10(1):38-44
pubmed: 12525762
Clin Cancer Res. 2012 Jun 15;18(12):3462-9
pubmed: 22421194
Cancer Res. 2010 Jan 15;70(2):560-7
pubmed: 20068178
Breast Cancer Res. 2021 Mar 6;23(1):31
pubmed: 33676547
Cancer Sci. 2021 Jan;112(1):454-464
pubmed: 33075187
N Engl J Med. 2007 Apr 5;356(14):1399-409
pubmed: 17409321
Tumour Biol. 2012 Dec;33(6):1837-43
pubmed: 22744714
Mol Genet Genomic Med. 2020 Feb;8(2):e1079
pubmed: 31867841
Crit Rev Oncog. 2013;18(1-2):153-61
pubmed: 23237557
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16368-73
pubmed: 16258065
J Clin Med. 2021 Feb 19;10(4):
pubmed: 33669778
Anticancer Res. 1999 Jul-Aug;19(4C):3511-5
pubmed: 10629644
N Engl J Med. 2013 Mar 28;368(13):1199-209
pubmed: 23484797
Breast Cancer Res Treat. 2014 Jul;146(1):163-74
pubmed: 24838941
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
Breast Cancer Res Treat. 2010 Apr;120(2):461-7
pubmed: 20107891
Int J Cancer. 2012 Oct 1;131(7):E1166-72
pubmed: 22407753
Am J Case Rep. 2017 Jan 09;18:26-32
pubmed: 28065930
Int J Cancer. 2015 May 1;136(9):2158-65
pubmed: 25307450
EMBO Mol Med. 2015 Aug;7(8):1034-47
pubmed: 25987569
Sensors (Basel). 2021 Jul 03;21(13):
pubmed: 34283105
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
Med Oncol. 2020 Mar 16;37(4):29
pubmed: 32180032
JAMA Oncol. 2020 Sep 1;6(9):1410-1415
pubmed: 32644110
J Clin Med. 2019 Aug 07;8(8):
pubmed: 31394872
EBioMedicine. 2018 Jun;32:111-118
pubmed: 29807833
Med Image Anal. 2021 Oct;73:102138
pubmed: 34274690
Clin Cancer Res. 2019 Jul 15;25(14):4255-4263
pubmed: 30992300
Clin Chem. 2017 Mar;63(3):691-699
pubmed: 28073896
J Clin Oncol. 2013 Mar 1;31(7):961-5
pubmed: 23129741
Clin Breast Cancer. 2017 Feb;17(1):61-69.e3
pubmed: 27395416
Breast Cancer Res Treat. 2006 Aug;98(3):241-8
pubmed: 16670941
Clin Chim Acta. 2010 Dec 14;411(23-24):1869-74
pubmed: 20816948
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
Anticancer Res. 2017 Sep;37(9):5065-5070
pubmed: 28870935
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Lett. 2006 Nov 8;243(1):64-70
pubmed: 16412565
Ann Oncol. 2021 Feb;32(2):229-239
pubmed: 33232761
Clin Biochem. 1997 Feb;30(1):53-6
pubmed: 9056110
Nanomedicine. 2021 Jul;35:102407
pubmed: 33905828

Auteurs

Mira Shoukry (M)

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.

Sacha Broccard (S)

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.

Jamie Kaplan (J)

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.

Emmanuel Gabriel (E)

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.

Classifications MeSH